Innoviva, Inc. (THRX)

Theseus Pharmaceuticals Revenue

In the year 2024, Theseus Pharmaceuticals had annual revenue of $358.71M with 15.54% growth. Theseus Pharmaceuticals had revenue of $91.81M in the quarter ending December 31, 2024, with 6.95% growth.

• Revenue (ttm): $358.71M
• Revenue Growth: +15.54%
• P/S Ratio: 3.19
• Revenue / Employee: $2,824,496
• Employees: 127
• Market Cap: 1.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	358.71M	48.25M	15.54%
Dec 31, 2023	310.46M	-20.88M	-6.30%
Dec 31, 2022	331.34M	-60.53M	-15.45%
Dec 31, 2021	391.87M	55.07M	16.35%
Dec 31, 2020	336.79M	75.78M	29.03%